Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

B-Raf IN 17

SKU: orb3133799

Description

B-Raf IN 17 (Compound 8e) is an effective, orally active type II multi-kinase inhibitor. It shows potent cellular inhibition against BRAFWT, VEGFR-2, and FGFR-1 in the A375 cell line, with IC50 values of 0.02, 0.18, and 1.65 μM, respectively. B-Raf IN 17 is applicable for cancer research.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

FormulaC22H14BrN5O2
TargetVEGFR,Raf,FGFR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Encorafenib [orb1300725]

    99.87% (May vary between batches)

    1269440-17-6

    540.01

    C22H27ClFN7O4S

    25 mg, 1 mg, 5 mg, 10 mg, 50 mg
  • Encorafenib [orb1222780]

    >98% (HPLC)

    1269440-17-6

    540.01

    C22H27ClFN7O4S

    5 mg, 10 mg, 25 mg, 100 mg, 200 mg, 500 mg, 1 g, 50 mg
  • Plx-4032 [orb1219665]

    >98% (HPLC)

    1029872-54-5

    489.92

    C23H18ClF2N3O3S

    10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
  • Trametinib [orb1223790]

    >98% (HPLC)

    871700-17-3

    615.3948

    C26H23FIN5O4

    5 mg, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
  • Vemurafenib [orb1223651]

    >98% (HPLC)

    918504-65-1

    489.9221

    C23H18ClF2N3O3S

    10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information